Roberta Fenoglio

Coordinating Center Of The Network For Rare Diseases Of Piedmont And Aosta Valley
Turin, 10154, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 94 publications

Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Report from the 34th Acute Disease Quality Initiative (ADQI) Consensus Conference.

Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Report from the 34th Acute Disease Quality Initiative (ADQI) Consensus Conference.

Journal: Journal of the American Society of Nephrology : JASN

Published: July 31, 2026

Current practices in antibiotic prophylaxis for patients on complement inhibitors: a multicenter survey across ERN ERKnet centers.

Current practices in antibiotic prophylaxis for patients on complement inhibitors: a multicenter survey across ERN ERKnet centers.

Journal: Clinical kidney journal

Published: July 14, 2026

Targeting CD38 Across Autoimmune and Plasma Cell-Driven Immune-Mediated Diseases: Rationale, Clinical Evidence, and Emerging Therapeutic Landscape.

Targeting CD38 Across Autoimmune and Plasma Cell-Driven Immune-Mediated Diseases: Rationale, Clinical Evidence, and Emerging Therapeutic Landscape.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: July 02, 2026

Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Report from the 34th Acute Disease Quality Initiative (ADQI) Consensus Conference.

Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Report from the 34th Acute Disease Quality Initiative (ADQI) Consensus Conference.

Journal: Journal of the American Society of Nephrology : JASN

Published: March 19, 2026

A multi-center cohort study evaluated hemoglobinuria as a marker of inflammation in IgA nephropathy.

A multi-center cohort study evaluated hemoglobinuria as a marker of inflammation in IgA nephropathy.

Journal: Kidney international

Published: February 18, 2026

Caveolin-1 as a Marker of Endothelial Damage in Primary Antiphospholipid Syndrome Nephropathy.

Caveolin-1 as a Marker of Endothelial Damage in Primary Antiphospholipid Syndrome Nephropathy.

Journal: Kidney medicine

Published: February 02, 2026

Unveiling the silent burden: high prevalence of occult nephropathies in radical nephrectomy specimens.

Unveiling the silent burden: high prevalence of occult nephropathies in radical nephrectomy specimens.

Journal: Clinical kidney journal

Published: January 24, 2026

Regional Citrate Anticoagulation in CRRT: Successes, Pitfalls, and Sustainability from a Long-Term Single-Center Experience.

Regional Citrate Anticoagulation in CRRT: Successes, Pitfalls, and Sustainability from a Long-Term Single-Center Experience.

Journal: Journal of clinical medicine

Published: December 31, 2025

Integrating Anti-Phosphatidylserine/Prothrombin Antibodies Testing into Antiphospholipid Syndrome Diagnostics: A Multidomain, Expert Perception-Based Health Technology Assessment.

Integrating Anti-Phosphatidylserine/Prothrombin Antibodies Testing into Antiphospholipid Syndrome Diagnostics: A Multidomain, Expert Perception-Based Health Technology Assessment.

Journal: Diagnostics (Basel, Switzerland)

Published: November 28, 2025

The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup.

The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup.

Journal: Nature reviews. Nephrology

Published: October 24, 2025

Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case study.

Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case study.

Journal: Journal of autoimmunity

Published: October 16, 2025

Thrombocytopenia in antiphospholipid syndrome: predictors, prognostic implications, and thrombotic risk in a large cohort study.

Thrombocytopenia in antiphospholipid syndrome: predictors, prognostic implications, and thrombotic risk in a large cohort study.

Journal: Thrombosis research

Published: October 14, 2025

Showing 1-12 of 94

Last Updated: 09/26/2026